Addition of Teicoplanin or Vancomycin for the Treatment of Documented Bacteremia due to Gram-Positive Cocci in Neutropenic Patients with Hematological Malignancies: Microbiological, Clinical and Economic Evaluation

Publisher： Karger

E-ISSN： 1421-9794|50|2|81-87

ISSN： 0009-3157

Source： Chemotherapy, Vol.50, Iss.2, 2004-06, pp. : 81-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bacteremia in Patients with Hematological Malignancies

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 147-153

Karger

Access to resources Recommend Favorite

Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014)

By  

Chemotherapy, Vol. 62, Iss. 1, 2016-05 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

In vitro Activity of Daptomycin versus Linezolid and Vancomycin against Gram-Positive Uropathogens and Ampicillin against Enterococci, Causing Complicated Urinary Tract Infections

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 64-69

Karger

Access to resources Recommend Favorite

Antifungal Prophylaxis in Neutropenic Patients with Hematologic Malignancies: Is There a Real Benefit?

By  

Chemotherapy, Vol. 45, Iss. 3, 1999-04 ,pp. : 224-232

Karger

Access to resources Recommend Favorite

Antimicrobial Peptides Targeting Gram-Positive Bacteria

By Malanovic Nermina   Lohner Karl  

Pharmaceuticals, Vol. 9, Iss. 3, 2016-09 ,pp. : 59-59

MDPI

Access to resources Recommend Favorite